WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 17.46 HKD 0.46% Market Closed
Market Cap: 72.5B HKD
Have any thoughts about
WuXi Biologics (Cayman) Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
WuXi Biologics (Cayman) Inc

Wall Street analysts forecast WuXi Biologics (Cayman) Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 21.03 HKD with a low forecast of 8.59 HKD and a high forecast of 36.75 HKD.

Lowest
Price Target
8.59 HKD
51% Downside
Average
Price Target
21.03 HKD
20% Upside
Highest
Price Target
36.75 HKD
110% Upside
WuXi Biologics (Cayman) Inc Competitors:
Price Targets
1SXP
SCHOTT Pharma AG & Co KgaA
28% Upside
GENO
Genovis AB
62% Upside
SHC
Sotera Health Co
22% Upside
300404
Boji Medical Technology Co Ltd
33% Upside
CDXS
Codexis Inc
40% Upside
DIM
Sartorius Stedim Biotech SA
21% Upside
CGEN
Compugen Ltd
251% Upside
1521
Frontage Holdings Corp
8% Downside

Revenue
Forecast

Revenue Estimate
WuXi Biologics (Cayman) Inc

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's revenue is 53%. The projected CAGR for the next 4 years is 11%.

53%
Past Growth
11%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
WuXi Biologics (Cayman) Inc

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's operating income is 69%. The projected CAGR for the next 4 years is 15%.

69%
Past Growth
15%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
WuXi Biologics (Cayman) Inc

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's net income is 72%. The projected CAGR for the next 4 years is 12%.

72%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WuXi Biologics (Cayman) Inc's stock price target?
Price Target
21.03 HKD

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 21.03 HKD with a low forecast of 8.59 HKD and a high forecast of 36.75 HKD.

What is WuXi Biologics (Cayman) Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's revenue is 53%. The projected CAGR for the next 4 years is 11%.

What is WuXi Biologics (Cayman) Inc's Operating Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's operating income is 69%. The projected CAGR for the next 4 years is 15%.

What is WuXi Biologics (Cayman) Inc's Net Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's net income is 72%. The projected CAGR for the next 4 years is 12%.

Back to Top